In conclusion, we have demonstrated, for the first time, the successful delivery of STAT5A siRNA via polymeric carriers into ALL cell lines, which was accompanied by marked inhibition of STAT5A expression (confirmed only at mRNA levels) and reductions in cell viability and proliferation. This evidence concerns the gene STAT5A and acute lymphoblastic leukemia.